Skip to main content

Management of Acute Food Protein-Induced Enterocolitis Syndrome (FPIES) Reactions

  • Chapter
  • First Online:
  • 316 Accesses

Abstract

Acute FPIES reactions are characterized by different severity degrees (mild, moderate, and severe). The clinical management will involve different approaches depending on the severity of the reactions, with rehydration being the cornerstone of FPIES treatment. Oral rehydration at home is recommended in mild reactions, whereas intravenous fluid resuscitation is mandatory in severe forms characterized by protracted emesis, lethargy, pallor, diarrhea, hypotension, and metabolic acidosis. Indeed, acute FPIES can lead to hypovolemic shock, and consequently, the priority in management is restoration of hemodynamic stability. Recently, a possible role for parenteral ondansetron in controlling acute symptoms was suggested and recommended in severe reactions. In order to reduce a presumed cell-mediated inflammation, a single dose of intravenous methylprednisolone could be administered. Epinephrine autoinjectors are not recommended, because the hypotension occurred during a severe reaction is the result of fluid loss from the gastrointestinal symptoms. Epinephrine IV may be needed in case of hypovolemic shock not responsive to rehydration. The monitoring and measurement of vital signs is useful for providing real-time data and necessary to assess the clinical situation of the patient. If a progressive clinical worsening should be highlighted, the patient must be transferred to the intensive care unit for managing extreme lethargy, respiratory distress, persistent or severe hypotension even to a hypovolemic shock condition. A possible discharge can occur only when the clinical condition is completely restored, and the patient is able to tolerate oral fluids again. The history of severe FPIES reaction makes necessary to call immediately an ambulance or go to the nearest emergency department.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Powell GK. Enterocolitis in low-birth-weight infants associated with milk and soy protein intolerance. J Pediatr. 1976;88(5):840–4.

    Article  CAS  Google Scholar 

  2. Nowak-Węgrzyn A, et al. International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: executive summary-Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2017;139(4):1111–1126.e4.

    Article  Google Scholar 

  3. Fiocchi A, Claps A, Dahdah L, Brindisi G, Dionisi-Vici C, Martelli A. Differential diagnosis of food protein-induced enterocolitis syndrome. Curr Opin Allergy Clin Immunol. 2014;14(3):246–54.

    Article  CAS  Google Scholar 

  4. Monti G, et al. Food protein-induced enterocolitis syndrome by cow’s milk proteins passed through breast milk. J Allergy Clin Immunol. 2011;127(3):679–80.

    Article  Google Scholar 

  5. Tan J, Campbell D, Mehr S. Food protein-induced enterocolitis syndrome in an exclusively breast-fed infant-an uncommon entity. J Allergy Clin Immunol. 2012;129(3):873.

    Article  Google Scholar 

  6. Kimura M, Ito Y, Tokunaga F, Meguro T, Shimomura M, Morishita H, Seto S. Increased C-reactive protein and fever in Japanese infants with food protein-induced enterocolitis syndrome. Pediatr Int. 2016;58(9):826–30.

    Article  CAS  Google Scholar 

  7. Kimura M, Ito Y, Shimomura M, Morishita H, Meguro T, Adachi Y, Seto S. Cytokine profile after oral food challenge in infants with food protein-induced enterocolitis syndrome. Allergol Int. 2017;66(3):452–7.

    Article  CAS  Google Scholar 

  8. Pecora V, Prencipe G, Valluzzi R, Dahdah L, Insalaco A, Cianferoni A, De Benedetti F, Fiocchi A. Inflammatory events during food protein-induced enterocolitis syndrome reactions. Pediatr Allergy Immunol. 2017;28(5):464–70.

    Article  Google Scholar 

  9. Dahdah L, Fiocchi A, Mazzina O, et al. FPIES: effects of educational intervention in an Italian children hospital. Allergy. 2014;60(Suppl 99):167.

    Google Scholar 

  10. Sicherer SH. Food protein-induced enterocolitis syndrome: case presentations and management lessons. J Allergy Clin Immunol. 2005;115(1):149–56.

    Article  Google Scholar 

  11. Holbrook T, Keet CA, Frischmeyer-Guerreiro PA, Wood RA. Use of ondansetron for food protein-induced enterocolitis syndrome. J Allergy Clin Immunol. 2013;135(5):1219–20.

    Article  Google Scholar 

  12. Miceli Sopo SM, Battista A, Greco M, Monaco S. Ondansetron for food protein-induced enterocolitis syndrome. Int Arch Allergy Immunol. 2014;164:137–9.

    Article  CAS  Google Scholar 

  13. Cunningham RS. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy. Oncol Nurs Forum. 1997;24(7 Suppl):33–40.

    CAS  PubMed  Google Scholar 

  14. Tomasik E, Ziółkowska E, Kołodziej M, Szajewska H. Systematic review with meta-analysis: ondansetron for vomiting in children with acute gastroenteritis. Aliment Pharmacol Ther. 2016;44(5):438–46.

    Article  CAS  Google Scholar 

  15. Bradley PB, Engel G, Feniuk W, et al. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 1986;25:563–76.

    Article  CAS  Google Scholar 

  16. Doggrell SA, Hancox JC. Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia. Expert Opin Drug Saf. 2013;12(3):421–31.

    Article  CAS  Google Scholar 

  17. Miceli Sopo S, Bersani G, Monaco S, Cerchiara G, Lee E, Campbell D, Mehr S. Ondansetron in acute food protein-induced enterocolitis syndrome, a retrospective case-control study. Allergy. 2017;72(4):545–51.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valentina Pecora .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fiocchi, A.G., Pecora, V. (2019). Management of Acute Food Protein-Induced Enterocolitis Syndrome (FPIES) Reactions. In: Brown-Whitehorn, T., Cianferoni, A. (eds) Food Protein Induced Enterocolitis (FPIES). Springer, Cham. https://doi.org/10.1007/978-3-030-21229-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21229-2_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21228-5

  • Online ISBN: 978-3-030-21229-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics